MOLECULAR PARTNERS AG (MOLN) Social Stream
Molecular Partners Ag (MOLN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MOLN.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
MOLN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MOLN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Molecular Partners Ag's variance in analysts' estimates is lower than -156.45% of them.
- To contextualize these metrics, consider that out of all US stocks, Molecular Partners Ag's number of analysts covering the stock is higher than 57.03% of them.
- In the context of Pharmaceutical Products stocks, Molecular Partners Ag's upside potential (average analyst target price relative to current price) is greater than 73.51% of them.
- Molecular Partners Ag's average analyst price target is greater than 224.32% of stocks in the small market cap category.
Make investment decisions regarding MOLN using the data that counts. Try POWR Ratings for free.